MQL: Media, Reproductive
What it covers
Reproductive media and supplement are products that are used for assisted reproduction procedures. Media include liquid and powder versions of various substances that come in direct physical contact with human gametes or embryos (including water, acid solutions used to treat gametes or embryos, rinsing solutions, sperm separation media, supplements, or oil used to cover the media) for the purposes of preparation, maintenance, transfer or storage. Supplements are specific reagents added to media to enhance specific properties of the media (e.g., proteins, sera, antibiotics, etc.).
The identification in 21 CFR 884.6180, reproductive media and supplements. FDA gives MQL no definition of its own, so the regulation’s describes it.
Recent clearances
| 510(k) | Device | Applicant | Decision | Type |
|---|---|---|---|---|
| K254261 | Vitrification Freeze Kit and Thawing Kit (CS-IVF-FK; CS-IVF-TK) | CELL STORE (BEIJING) BIOTECHNOLOGY CO., LTD. | Aug 28, 2026 | Traditional |
| K260248 | Ultra-Fast Warm | Kitazato Corporation | Apr 28, 2026 | Traditional |
| K252672 | CaseBio Culture w/HSA (CMH5); CaseBio Handling w/HSA (WHH5) | Casebioscience, Inc. | Feb 20, 2026 | Traditional |
| K250445 | Fast Warm - NX | Fujifilm Irvine Scientific | Sep 12, 2025 | Traditional |
| K251637 | Dewin Reproductive Media (Dewin Gamete Buffer [with HSA and without HSA]; Dewin Follicle Flushing Solution, Dewin One Step medium [with HSA and without HSA]) | Donnevie Medical Technology (Shanghai) Co. , Ltd. | Aug 27, 2025 | Traditional |
| K251305 | Ultra-Fast Vitri; Ultra-Fast Warm | Kitazato Corporation | Aug 26, 2025 | Traditional |
| K242640 | FertiCult Flushing medium; FertiCult Flushing medium with phenol red and gentamicin | Fertipro NV | May 30, 2025 | Traditional |
| K242561 | Dewin Reproductive Media (Dewin Vitrification Kit, Dewin Thawing Kit) | Donnevie Medical Technology (Shanghai) Co. , Ltd. | Apr 10, 2025 | Traditional |
| K242089 | Vitrification Freeze Kit (RFD-0101) Vitrification Thaw Kit (RFD-0201, RFD-0202) | Jiangsu Ruifuda Medical Device Co., Ltd. | Apr 10, 2025 | Traditional |
| K241833 | V-GRAD | Vitromed GmbH | Mar 21, 2025 | Traditional |
Clearances by year
91 MQL 510(k)s were cleared from 2011 to Oct 29, 2026. Days to decision run from the day FDA received the 510(k) to its decision, including time on hold.
| Year | Clearances | Median days to decision |
|---|---|---|
| 2026 (so far) | 3 | 179 |
| 2025 | 9 | 225 |
| 2024 | 12 | 195 |
| 2023 | 5 | 199 |
| 2022 | 3 | 316 |
| 2021 | 1 | 228 |
| 2020 | 8 | 257 |
| 2019 | 6 | 170 |
| 2018 | 4 | 94 |
| 2017 | 10 | 113 |
| 2016 | 12 | 170 |
| 2015 | 7 | 87 |
| 2014 | 5 | 142 |
| 2012 | 5 | 253 |
| 2011 | 1 | 476 |
Who submits
34 applicants cleared a MQL device since 2011. 25% of the clearances went to applicants in United States, then China (19%), Australia (15%) and Denmark (13%). By type: Traditional 86%, Special 13% and Abbreviated 1%.
| Applicant | Clearances since 2011 |
|---|---|
| Origio A/S | 9 |
| William A. Cook Australia Pty. , Ltd. | 9 |
| Kitazato Corporation | 8 |
| Vitromed GmbH | 6 |
| Gimbo Medical Technology Shenzhen Co., Ltd. | 5 |
| Irvine Scientific Sales Co., Inc. | 5 |
| Vitrolife Sweden AB | 5 |
| Donnevie Medical Technology (Shanghai) Co. , Ltd. | 4 |
How FDA classifies it
Class II (special controls) (mouse embryo assay information, endotoxin testing, sterilization validation, design specifications, labeling requirements, biocompatibility testing, and clinical testing). The device, when it is phosphate-buffered saline used for washing, and short-term handling and manipulation of gametes and embryos; culture oil used as an overlay for culture media containing gametes and embryos; and water for assisted reproduction applications, is exempt from the premarket notification procedures in subpart E of part 807 of this chapter subject to the limitations in § 884.9.
From 21 CFR 884.6180. Special controls are the requirements a 510(k) must show it meets.
Standards
21 CFR 884.6180 names no consensus standards. Check FDA’s recognized standards database, or ask which standards recent MQL clearances declared.
Ask about MQL
Questions about MQL
What is FDA product code MQL?
Product code MQL, “Media, Reproductive” in FDA's classification database, is a Class II device type under 21 CFR 884.6180 (reproductive media and supplements), reviewed by FDA's Obstetrics/Gynecology panel. FDA's 510(k) database lists 260 clearances under MQL, 91 of them since 2011.
How many 510(k) clearances are there under MQL?
FDA’s 510(k) database listed 260 clearances under MQL as of Oct 29, 2026, 91 of them decided since 2011; the most recent decision was Aug 28, 2026. The Predicate Finder searches the live database.
How long does FDA take to clear a MQL 510(k)?
For the 15 MQL clearances decided in the two years before Oct 29, 2026, the median time from FDA receiving the 510(k) to its decision was 225 days. That counts calendar days, including time the submission was on hold waiting for answers from the submitter.
Which companies have the most MQL clearances?
Since 2011: Origio A/S (9), William A. Cook Australia Pty. , Ltd. (9), Kitazato Corporation (8), Vitromed GmbH (6) and Gimbo Medical Technology Shenzhen Co., Ltd. (5). 34 applicants have cleared a MQL device in that time.